Greenwood Capital Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,111
| Closed | -$646K | – | 259 |
|
|
2024
Q1 | $646K | Sell |
1,111
-40
| -3% | -$23.2K | 0.09% | 173 |
|
|
2023
Q4 | $611K | Sell |
1,151
-13,207
| -92% | -$7.01M | 0.08% | 173 |
|
|
2023
Q3 | $7.27M | Sell |
14,358
-110
| -0.8% | -$55.7K | 1.06% | 28 |
|
|
2023
Q2 | $7.55M | Sell |
14,468
-3,582
| -20% | -$1.87M | 1.06% | 31 |
|
|
2023
Q1 | $10.4M | Sell |
18,050
-6,220
| -26% | -$3.59M | 1.49% | 13 |
|
|
2022
Q4 | $13.4M | Sell |
24,270
-518
| -2% | -$285K | 2.19% | 7 |
|
|
2022
Q3 | $12.6M | Buy |
24,788
+824
| +3% | +$418K | 2.16% | 8 |
|
|
2022
Q2 | $13M | Buy |
23,964
+3,670
| +18% | +$1.99M | 2.08% | 8 |
|
|
2022
Q1 | $12M | Buy |
20,294
+4,724
| +30% | +$2.79M | 3.15% | 9 |
|
|
2021
Q4 | $10.4M | Sell |
15,570
-215
| -1% | -$143K | 1.47% | 20 |
|
|
2021
Q3 | $9.02M | Buy |
15,785
+1,338
| +9% | +$764K | 1.39% | 22 |
|
|
2021
Q2 | $7.29M | Buy |
14,447
+958
| +7% | +$483K | 1.1% | 35 |
|
|
2021
Q1 | $6.16M | Buy |
13,489
+67
| +0.5% | +$30.6K | 0.97% | 35 |
|
|
2020
Q4 | $6.25M | Sell |
13,422
-208
| -2% | -$96.9K | 1.05% | 34 |
|
|
2020
Q3 | $6.02M | Buy |
13,630
+399
| +3% | +$176K | 1.17% | 30 |
|
|
2020
Q2 | $4.79M | Buy |
13,231
+40
| +0.3% | +$14.5K | 1.09% | 38 |
|
|
2020
Q1 | $3.74M | Buy |
+13,191
| New | +$3.74M | 1.1% | 40 |
|